Loading...
ACTR-62. A PHASE II STUDY OF TUMOR TREATING FIELDS (TTFIELDS) WITH TEMOZOLOMIDE IN PATIENTS WITH LOW-GRADE GLIOMAS
Approximately 2,000 to 3,000 adults are diagnosed with low-grade gliomas (LGGs) annually in the United States, with a median overall survival ranging from 3–9 years. Radiation and chemotherapy are used to treat LGGs but can increase the risk of transformation to high-grade tumors (HGG) and cause cog...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692887/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.051 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|